Strategic Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Strategic Wealth Partners's GILD Position: Q1 2026 in Review
Strategic Wealth Partners increased its Gilead Sciences (GILD) stake by 3.3% in Q1 2026, buying an estimated $980 and bringing the position to 222 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #611.
Strategic Wealth Partners first reported a position in GILD in Q4 2017 and has held it in 21 quarters since. The position peaked at $5.58M in Q4 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Strategic Wealth Partners held 222 shares of Gilead Sciences worth $30.9K as of Q1 2026.
- Strategic Wealth Partners bought 7 Gilead Sciences shares in Q1 2026, an estimated $980.
- Gilead Sciences made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #611 holding.
- Strategic Wealth Partners first reported a position in Gilead Sciences in Q4 2017 and has held it in 21 quarters since.
- Strategic Wealth Partners's Gilead Sciences position peaked at $5.58M in Q4 2021.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.